Clinical Trial Update: Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating diltiazem for atrial fibrillation or atrial flutter with rapid ventricular rate; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Diltiazem (diltiazem)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Atrial Fibrillation With Rapid Ventricular Response, Hypotension Drug-Induced | Phase 4 | Status: COMPLETED | Results posted: 2025-11-10